Shock and Tissue Injury Induced by Recombinant Human Cachectin

An endotoxin-induced serum factor that causes necrosis of tumors

Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532 · see citing works

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S. F., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., Skibber, J. M., Shiloni, E., Vetto, J. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132327 · Cited by 2,653 · see citing works

Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin

Beutler, B., Milsark, I. W., & Cerami, A. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,369 · see citing works

Cachectin and tumour necrosis factor as two sides of the same biological coin

Beutler, B., & Cerami, A. (1986) · Nature · doi:10.1038/320584a0 · Cited by 1,633 · see citing works

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472 · see citing works

Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Nawroth, P. P., & Stern, D. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.3.740 · Cited by 1,325 · see citing works

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J. C., Ulevitch, R. J., & Cerami, A. (1985) · Nature · doi:10.1038/316552a0 · Cited by 1,132 · see citing works

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.

Gamble, J. R., Harlan, J. M., Klebanoff, S. J., & Vadas, M. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8667 · Cited by 1,031 · see citing works

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.

Dahlén, S., Björk, J., Hedqvist, P., Arfors, K. E., Hammarström, S., Lindgren, J. A., & Samuelsson, B. O. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3887 · Cited by 1,019 · see citing works

Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

Shalaby, M. R., Aggarwal, B. B., Rinderknecht, E., Svedersky, L. P., Finkle, B. S., & Palladino, M. A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.2069 · Cited by 916 · see citing works

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.

Beutler, B., Mahoney, J., Trang, N. L., Pekala, P. H., & Cerami, A. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.161.5.984 · Cited by 821 · see citing works

Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

Beutler, B., Milsark, I. W., & Cerami, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3972 · Cited by 771 · see citing works

Comparison of in vitro cell cytotoxic assays for tumor necrosis factor

Flick, D. A., & Gifford, G. E. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90147-9 · Cited by 745 · see citing works

Multiple System Organ Failure

Fry, D. E. (1980) · Archives of Surgery · doi:10.1001/archsurg.1980.01380020006003 · Cited by 740 · see citing works

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.

Nawroth, P. P., Bank, I., Handley, D. A., Cassimeris, J., Chess, L., & Stern, D. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.6.1363 · Cited by 692 · see citing works

Alpha-factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae.

Brake, A. J., Merryweather, J. P., Coit, D. G., Heberlein, U., Masiarz, F. R., Mullenbach, G. T., Urdea, M. S., Valenzuela, P., & Barr, P. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4642 · Cited by 485 · see citing works

Patterns Of Septic Shock In Man—a Detailed Study Of 56 Patients

MacLean, L. D., Mulligan, W. G., McLean, A. P. H., & Duff, J. H. (1967) · Annals of Surgery · doi:10.1097/00000658-196710000-00004 · Cited by 384 · see citing works

Mechanisms of the Hemodynamic Effects of Endotoxin

Gilbert, R. P. (1960) · Physiological Reviews · doi:10.1152/physrev.1960.40.2.245 · Cited by 355 · see citing works

Studies of endotoxin-induced decrease in lipoprotein lipase activity.

Kawakami, M., & Cerami, A. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.154.3.631 · Cited by 331 · see citing works

Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. studies with paf-receptor antagonist kadsurenone

Doebber, T. W., Wu, M. S., Robbins, J. C., Choy, B. M., Chang, M. N. T., & Shen, T. Y. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(85)80014-0 · Cited by 294 · see citing works

The Genetic Mapping of a Defective Lps Response Gene in C3H/HeJ Mice

Watson, J. D., Kelly, K., Largen, M. T., & Taylor, B. A. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.2.422 · Cited by 277 · see citing works

Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells.

Kawakami, M., Pekala, P. H., Lane, M. D., & Cerami, A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.3.912 · Cited by 267 · see citing works

Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

McManus, L. M., Hanahan, D. J., Demopoulos, C. A., & Pinckard, R. N. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.6.2919 · Cited by 261 · see citing works

Potent ulcerogenic actions of platelet-activating factor on the stomach

Rosam, A.-C., Wallace, J. L., & Whittle, B. J. R. (1986) · Nature · doi:10.1038/319054a0 · Cited by 247 · see citing works

Is platelet activating factor (PAF) a mediator of endotoxin shock?

Terashita, Z., Imura, Y., Nishikawa, K., & SUMIDA, S. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90427-3 · Cited by 247 · see citing works

The Primary Role of Lymphoreticnlar Cells in the Mediation of Host Responses to Bacterial Endotoxim

Michalek, S. M., Moore, R. N., McGhee, J. R., Rosenstreich, D. L., & Mergenhagen, S. E. (1980) · The Journal of Infectious Diseases · doi:10.1093/infdis/141.1.55 · Cited by 210 · see citing works

Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: The role of cachectin (tumor necrosis factor)

Cerami, A., Ikeda, Y., Le, T., Hotez, P. J., & Beutler, B. (1985) · Immunology Letters · doi:10.1016/0165-2478(85)90165-8 · Cited by 202 · see citing works

Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxin shock

Filkins, J., & Cornell, R. (1974) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1974.227.4.778 · Cited by 184 · see citing works

The determination of the dosage-mortality curve from small numbers

Bliss, C. I. (1938) · Quarterly Journal of Pharmacy and Pharmacology · Cited by 176 · see citing works

Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential.

Tracey, K. J., Lowry, S. F., Beutler, B., Cerami, A., Albert, J. D., & Shires, G. T. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.4.1368 · Cited by 171 · see citing works

The Intestinal Factor in Irreversible Endotoxin Shock

Lillehei, R. C., & MacLean, L. D. (1958) · Annals of Surgery · doi:10.1097/00000658-195810000-00002 · Cited by 161 · see citing works

Interactions of granulocytes with the lungs.

Brigham, K. L., & Meyrick, B. O. (1984) · Circulation Research · doi:10.1161/01.res.54.6.623 · Cited by 140 · see citing works

HEMODYNAMIC AND METABOLIC STUDIES ON SHOCK ASSOCIATED WITH GRAM NEGATIVE BACTEREMIA

Nishijima, H., Weil, M. H., Shubin, H., & Cavanilles, J. M. (1973) · Medicine · doi:10.1097/00005792-197307000-00007 · Cited by 123 · see citing works

BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies.

Vogel, S. N., Moore, R. N., Sipe, J. D., & Rosenstreich, D. L. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.4.2004 · Cited by 99 · see citing works

Role of Platelet-Activating Factor-Acether in Mediating Guinea Pig Anaphylaxis

Darius, H., Lefer, D. J., Smith, J. B., & Lefer, A. M. (1986) · Science · doi:10.1126/science.3082008 · Cited by 98 · see citing works

The pulmonary ultrastructure in septic shock

Coalson, J. J., Hinshaw, L. B., & Guenter, C. A. (1970) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(70)90077-8 · Cited by 91 · see citing works

Leukotriene antagonists prevent endotoxin lethality

Hagmann, W., & KEPPLER, D. O. R. (1982) · Die Naturwissenschaften · doi:10.1007/bf00396357 · Cited by 59 · see citing works

Purification of rabbit tumor necrosis factor

Abe, S., Gatanaga, T., Yamazaki, M., Soma, G., & Mizuno, D. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)81071-1 · Cited by 51 · see citing works

Morphologic changes in rabbits following the intravenous administration of meningococcal toxin. I. The effects produced in young and in mature animals by a single injection.

Brunson, J. G., Gamble, C. N., & Thomas, L. (2003) · PubMed · Cited by 37 · see citing works

Pathologic Changes Produced in Rabbits by a Toxic Somatic Antigen Derived from Eberthella Typhosa.

Morgan, H. R. (1943) · PubMed · Cited by 35 · see citing works

Generation of slow-reacting substance (leukotrienes) by endotoxin and lipid A from human polymorphonuclear granulocytes.

Bremm, K. D., König, W., Spur, B. W., Crea, A., & Galanos, C. (1984) · PubMed Central · Cited by 34 · see citing works

BLOOD SUGAR STUDIES

Zeckwer, I. T., & Goodell, H. (1925) · The Journal of Experimental Medicine · doi:10.1084/jem.42.1.43 · Cited by 21 · see citing works

Characterization of macrophage function in Mycobacterium lepraemurium‐infected mice: sensitivity of mice to endotoxin and release of mediators and lysosomal enzymes after endotoxin treatment

Ha, D. K. K., Gardner, I., & Lawton, J. W. M. (1983) · Parasite Immunology · doi:10.1111/j.1365-3024.1983.tb00765.x · Cited by 20 · see citing works

Action of Toxic Doses of the Polysaccharide from Serratia Marcescens (Bacillus Prodigiosus) on the Dog and Guinea Pig

Franke, F. E. (1944) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/5.3.185 · Cited by 11 · see citing works

Cardiovascular Responses of Unanesthetized Rats During Traumatic and Endotoxin Shock.

Ross, C. A. (1957) · Experimental Biology and Medicine · doi:10.3181/00379727-96-23547 · Cited by 10 · see citing works

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211 · see citing works

The inflammatory reflex

Tracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728 · see citing works

HMG-1 as a Late Mediator of Endotoxin Lethality in Mice

Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386 · see citing works

Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation

Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., et al. (2003) · Nature · doi:10.1038/nature01339 · Cited by 3,228 · see citing works

Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease

Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985 · see citing works

Secretory products of macrophages.

Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615 · see citing works

Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure

Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582 · see citing works

Lethal effect of the anti-Fas antibody in mice

Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881 · see citing works

The Staphylococcal Enterotoxins and Their Relatives

Marrack, P., & Kappler, J. W. (1990) · Science · doi:10.1126/science.2185544 · Cited by 1,895 · see citing works

The clinical implications of endothelial dysfunction

Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749 · see citing works

Detection of circulating tumor necrosis factor after endotoxin administration

Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677 · see citing works

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677 · see citing works

Physiology and immunology of the cholinergic antiinflammatory pathway

Tracey, K. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30555 · Cited by 1,563 · see citing works

Immune-neuro-endocrine interactions: facts and hypotheses.

BESEDOVSKY, H. O., & REY, A. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-64 · Cited by 1,564 · see citing works

Cachectin: More Than a Tumor Necrosis Factor

Epstein, F. H., Beutler, B., & Cerami, A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160705 · Cited by 1,423 · see citing works

High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes

Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401 · see citing works

Cytokine storm and sepsis disease pathogenesis

Chousterman, B. G., Świrski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,340 · see citing works

Sepsis: pathophysiology and clinical management

Gotts, J. E., & Matthay, M. A. (2016) · BMJ · doi:10.1136/bmj.i1585 · Cited by 1,269 · see citing works

Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein

Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., BALK, R. A., SADOFF, J. C., Abraham, E. H., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,239 · see citing works

The Tumor Necrosis Factor Ligand and Receptor Families

Bazzoni, F., & Beutler, B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342607 · Cited by 1,208 · see citing works

MIF as a glucocorticoid-induced modulator of cytokine production

Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T. M., Cerami, A., & Bucala, R. (1995) · Nature · doi:10.1038/377068a0 · Cited by 1,148 · see citing works

Interleukin-1 and Its Biologically Related Cytokines

Dinarello, C. A. (1989) · Advances in immunology · doi:10.1016/s0065-2776(08)60642-2 · Cited by 1,148 · see citing works

Reversing established sepsis with antagonists of endogenous high-mobility group box 1

Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126 · see citing works

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

Kim, S., Takahashi, H., Lin, W.-W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.-L., & Karin, M. (2009) · Nature · doi:10.1038/nature07623 · Cited by 1,100 · see citing works

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF

Kriegler, M., Perez, C. F., DeFay, K., Albert, I., & Lu, S.-D. (1988) · Cell · doi:10.1016/0092-8674(88)90486-2 · Cited by 1,090 · see citing works

TREM-1 amplifies inflammation and is a crucial mediator of septic shock

Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,092 · see citing works

Severe falciparum malaria

World Health Organization (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90300-6 · Cited by 1,083 · see citing works

Tumor necrosis factor: a pleiotropic cytokine and therapuetic target

Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063 · see citing works

The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games

Hehlgans, T., & Pfeffer, K. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02143.x · Cited by 1,049 · see citing works

Inflammatory Mediators and the Failing Heart

Mann, D. L. (2002) · Circulation Research · doi:10.1161/01.res.0000043825.01705.1b · Cited by 987 · see citing works

The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.

Calandra, T., Bernhagen, J., Mitchell, R. A., & Bucala, R. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.6.1895 · Cited by 984 · see citing works

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., & Dinarello, C. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113431 · Cited by 981 · see citing works

Critical protective role of mast cells in a model of acute septic peritonitis

Echtenacher, B., Männel, D. N., & Hültner, L. (1996) · Nature · doi:10.1038/381075a0 · Cited by 925 · see citing works

Serum Cytokine Levels in Human Septic Shock

Pinsky, M. R., Vincent, J., Deviere, J. M., Alegre, M., Kahn, R. J., & Dupont, É. (1993) · CHEST Journal · doi:10.1378/chest.103.2.565 · Cited by 880 · see citing works

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

OHLSSON, K., Björk, P., Bergenfeldt, M., Hageman, R. J. J., & Thompson, R. C. (1990) · Nature · doi:10.1038/348550a0 · Cited by 852 · see citing works

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

Zee, K. J. V., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L. L., & Lowry, S. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4845 · Cited by 845 · see citing works

Animal Models of sepsis: setting the stage

Buras, J. A., Holzmann, B., & Sitkovsky, M. V. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1854 · Cited by 838 · see citing works

Tumor Necrosis Factor and Disease Severity in Children with Falciparum Malaria

Grau, G. E., Taylor, T. E., Molyneux, M. E., Wirima, J. J., VASSALLI, P., Hommel, M., & Lambert, P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906153202404 · Cited by 839 · see citing works

Neutrophils in Human Diseases

Malech, H. L., & Gallin, J. I. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171107 · Cited by 840 · see citing works

Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

Colletti, L. M., Remick, D. G., Burtch, G. D., Kunkel, S. L., Strieter, R. M., & Campbell, D. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114656 · Cited by 817 · see citing works

Increased plasma levels of interleukin-6 in sepsis [see comments]

Hack, C. E., de Groot, E. R., Felt-Bersma, R. J. F., Nuijens, J. H., van Schijndel, R. J. M. S., Eerenberg, A. J. M., THIJS, L. G., & Aarden, L. A. (1989) · Blood · doi:10.1182/blood.v74.5.1704.1704 · Cited by 811 · see citing works

Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity

DAMA, P., Ledoux, D., Nys, M., Vrindts, Y., Groote, D. D., Franchimont, P., & Lamy, M. (1992) · Annals of Surgery · doi:10.1097/00000658-199204000-00009 · Cited by 808 · see citing works

Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.

Nathan, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113241 · Cited by 791 · see citing works

Persistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS

Meduri, G. U., Headley, S., Kohler, G., Stentz, F. B., Tolley, E. A., Umberger, R. A., & Leeper, K. V. (1995) · CHEST Journal · doi:10.1378/chest.107.4.1062 · Cited by 788 · see citing works

Novel strategies for the treatment of sepsis

Riedemann, N. C., Guo, R., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 774 · see citing works

The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation

Pavlov, V. A., Wang, H., Czura, C. J., Friedman, S. G., & Tracey, K. J. (2003) · Molecular Medicine · doi:10.1007/bf03402177 · Cited by 772 · see citing works

Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever

Cannon, J. G., Tompkins, R. G., Gelfand, J. A., MICHIE, H. R., Stanford, G. G., van der Meer, J. W. M., Endres, S., Lonnemann, G., Corsetti, J., Chernow, B., et al. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.1.79 · Cited by 752 · see citing works

Tumor necrosis factor in the heart

Meldrum, D. R. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.3.r577 · Cited by 747 · see citing works

Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura

Girardin, E. P., Grau, G. E., Dayer, J., Roux-Lombard, P., the J5 Study Group*, & Lambert, P.-H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190703 · Cited by 737 · see citing works

Tumor Necrosis Factor (Cachectin) as an Essential Mediator in Murine Cerebral Malaria

Grau, G. E., Fajardo, L. F., Piguet, P., Allet, B., Lambert, P., & VASSALLI, P. (1987) · Science · doi:10.1126/science.3306918 · Cited by 735 · see citing works

Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality

Mira, J. P., Cariou, A., Grall, F., Delclaux, C., Losser, M.-R., Heshmati, F., Cheval, C., Monchi, M., Teboul, J., Riché, F. C., et al. (1999) · JAMA · doi:10.1001/jama.282.6.561 · Cited by 732 · see citing works

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.

Tracey, K. J., He, W., Manogue, K. R., Fong, Y., HESSE, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., & Cerami, A. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.3.1211 · Cited by 726 · see citing works

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.

Liénard, D., Ewalenko, P., Delmotte, J.-B., Renard, N., & Lejeune, F. J. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.52 · Cited by 720 · see citing works

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

Yokoyama, T., Vaca, L. A., Rossen, R. D., Durante, W., Hazarika, P., & Mann, D. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116834 · Cited by 714 · see citing works

Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine

Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, W. E., Walker, M., Seidel, G., Yuldasheva, N., & Tamarkin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0978 · Cited by 717 · see citing works

Sepsis: Current Dogma and New Perspectives

Deutschman, C. S., & Tracey, K. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.001 · Cited by 676 · see citing works

Clinical implications of dysregulated cytokine production

Slifka, M. K., & Whitton, J. L. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000086 · Cited by 677 · see citing works

Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects

van der Poll, T., Buller, H. R., Cate, H. T., Wortel, C. H., Bauer, K. A., van Deventer, S. J. H., Hack, C. E., Sauerwein, H. P., ROSENBERG, R. D., & ten Cate, J. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006073222302 · Cited by 667 · see citing works

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.

Brockhaus, M., Schönfeld, H., Schlaeǵer, E.-J., Hunziker, W. H., Lesslauer, W., & Loetscher, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3127 · Cited by 649 · see citing works

Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α

Meier, B., Radeke, H. H., Selle, S., Younes, M., Sies, H., Resch, K., & Habermehl, G. (1989) · Biochemical Journal · doi:10.1042/bj2630539 · Cited by 650 · see citing works

Tumors secreting human TNF/cachectin induce cachexia in mice

Oliff, A. I., Defeo-Jones, D., BOYER, M. E., Martinez, D., KIEFER, D. M., Vuocolo, G. A., Wolfe, A. L., & Socher, S. H. (1987) · Cell · doi:10.1016/0092-8674(87)90028-6 · Cited by 640 · see citing works

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.

Fong, Y., Tracey, K. J., Moldawer, L. L., HESSE, D. G., Manogue, K., Kenney, J. S., Lee, A. T., Kuo, G. C., ALLISON, A. C., & Lowry, S. F. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.5.1627 · Cited by 640 · see citing works

The enigma of sepsis

Riedemann, N. C., Guo, R., & Ward, P. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19523 · Cited by 635 · see citing works

Kaempferol and inflammation: from chemistry to medicine

Devi, K. P., Malar, D. S., Nabavi, S. F., Sureda, A., Xiao, J., Nabavi, S. M., & Daglia, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.002 · Cited by 619 · see citing works

Superantigens and Their Potential Role in Human Disease

Kotzin, B. L., Leung, D. Y. M., Kappler, J. W., & Marrack, P. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60534-9 · Cited by 614 · see citing works

Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α

Bryant, D. D., Becker, L., Richardson, J. A., Shelton, J. M., Franco, F., Peshock, R. M., Thompson, M. T., & Giroir, B. P. (1998) · Circulation · doi:10.1161/01.cir.97.14.1375 · Cited by 593 · see citing works

RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome

Duprez, L., Takahashi, N., Hauwermeiren, F. V., Vandendriessche, B., Goossens, V., Berghe, T. V., Declercq, W., Libert, C., Cauwels, A., & Vandenabeele, P. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.020 · Cited by 591 · see citing works

Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.

Mathison, J. C., Wolfson, E. B., & Ulevitch, R. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113540 · Cited by 591 · see citing works

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation

Ulloa, L., Ochani, M., Yang, H., Tanovic, M., Halperin, D. M., Yang, R., Czura, C. J., Fink, M. P., & Tracey, K. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192222999 · Cited by 585 · see citing works

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.

Piguet, P. F., Grau, G. E., Allet, B., & VASSALLI, P. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.166.5.1280 · Cited by 584 · see citing works

Severe and complicated malaria

(1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90363-j · Cited by 573 · see citing works

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.

Natanson, C., Eichenholz, P. W., Danner, R. L., Eichacker, P. Q., Hoffman, W. D., Kuo, G. C., Banks, S. M., MacVittie, T. J., & Parrillo, J. E. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.3.823 · Cited by 566 · see citing works

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline

Strieter, R. M., Remick, D. G., Ward, P. A., Spengler, R. N., Lynch, J. P., Larrick, J. W., & Kunkel, S. L. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81271-3 · Cited by 561 · see citing works

Cytokines of the Lung

Kumar, R. K. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.5.1234 · Cited by 559 · see citing works

Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock

Calandra, T., Baumgartner, J. D., Grau, G. E., Wu, M.-M., Lambert, P., Schellekens, J. F. P., Verhoef, J., Glauser, M. P., & Swiss-Dutch J5 Immunoglobulin Study Group (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.5.982 · Cited by 546 · see citing works

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α

Ruan, H., & Lodish, H. F. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00052-2 · Cited by 541 · see citing works

Pharmacological stimulation of the cholinergic antiinflammatory pathway

Bernik, T. R., Friedman, S. G., Ochani, M., DiRaimo, R., Ulloa, L., Yang, H., Sudan, S., Czura, C. J., Ivanova, S. M., & Tracey, K. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011714 · Cited by 529 · see citing works

Sepsis and Acute Kidney Injury

Zarjou, A., & Agarwal, A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050484 · Cited by 521 · see citing works

High Bronchoalveolar Levels of Tumor Necrosis Factor and Its Inhibitors, Interleukin-1, Interferon, and Elastase, in Patients with Adult Respiratory Distress Syndrome after Trauma, Shock, or Sepsis

Suter, P. M., Suter, S., Girardin, E. P., Roux‐Lombard, P., Grau, G. E., & Dayer, J. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.5.1016 · Cited by 516 · see citing works

Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.

Lang, C. H., Dobrescu, C., & Bagby, G. J. (1992) · Endocrinology · doi:10.1210/endo.130.1.1727716 · Cited by 535 · see citing works

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.

Han, J. S., Thompson, P., & Beutler, B. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.1.391 · Cited by 508 · see citing works

The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding.

Eck, M. J., & Sprang, S. R. (1989) · PubMed · doi:10.2210/pdb1tnf/pdb · Cited by 507 · see citing works

Tumor necrosis factor-α

Rock, C. S., & Lowry, S. F. (1991) · Journal of Surgical Research · doi:10.1016/0022-4804(91)90146-d · Cited by 506 · see citing works

Pathophysiology of Sepsis

Remick, D. G. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060872 · Cited by 502 · see citing works

INTERSEPT

Cohen, J., & Carlet, J. M. (1996) · Critical Care Medicine · doi:10.1097/00003246-199609000-00002 · Cited by 499 · see citing works

Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models.

Leist, M., Gantner, F., Bohlinger, I., Tiegs, G., Germann, P., & Wendel, A. (1995) · Europe PMC (PubMed Central) · Cited by 493 · see citing works

Jun N-Terminal Kinase/Stress-Activated Protein Kinase (JNK/SAPK) Is Required for Lipopolysaccharide Stimulation of Tumor Necrosis Factor Alpha (TNF-α) Translation: Glucocorticoids Inhibit TNF-α Translation by Blocking JNK/SAPK

Swantek, J. L., Cobb, M. H., & Geppert, T. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6274 · Cited by 491 · see citing works

HMGB1 as a Late Mediator of Lethal Systemic Inflammation

Wang, H., Yang, H., Czura, C. J., Sama, A. E., & Tracey, K. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2106117 · Cited by 490 · see citing works

Peptide Regulatory Factors

Tracey, K. J., Vlassara, H., & Cerami, A. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92394-5 · Cited by 486 · see citing works

Systemic inflammatory response syndrome

Davies, M. G., & Hagen, P.-O. (1997) · British journal of surgery · doi:10.1002/bjs.1800840707 · Cited by 488 · see citing works

Dietary modification of inflammation with lipids

Calder, P. C. (2002) · Proceedings of The Nutrition Society · doi:10.1079/pns2002166 · Cited by 486 · see citing works

Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice.

Xu, H., Gonzalo, J. A., St‐Pierre, Y., Williams, I. R., Kupper, T. S., Cotran, R. S., Springer, T. A., & Gutierrez‐Ramos, J. C. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.1.95 · Cited by 483 · see citing works

The Structure of Tumor Necrosis Factor-α at 2.6 Å Resolution

Eck, M. J., & Sprang, S. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71533-0 · Cited by 585 · see citing works

Bacterial Endotoxin: Chemical Constitution, Biological Recognition, Host Response, and Immunological Detoxification

Rietschel, E., Brade, H., Holst, O., Brade, L., Müller‐Loennies, S., Mamat, U., Zähringer, U., Beckmann, F., Seydel, U., Brandenburg, K., et al. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80186-0_3 · Cited by 469 · see citing works

Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in mice

Wysocka, M., Kubin, M. Z., Vieira, L. Q., Ozmen, L., Garotta, G., Scott, P., & Trinchieri, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250307 · Cited by 452 · see citing works

Cytokines of the Lung

Kelley, J. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.3.765 · Cited by 460 · see citing works

Role of NFkappaB in the mortality of sepsis.

Bohrer, H., Qiu, F., Zimmermann, T. P., Zhang, Y., Jllmer, T., Männel, D. N., Böttiger, B. W., Stern, D., Waldherr, R., Saeger, H.-D., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119648 · Cited by 454 · see citing works

Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.

Waage, A., Halstensen, A. I., Shalaby, R., Brandtzaeg, P., Kierulf, P., & Espevik, T. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.6.1859 · Cited by 454 · see citing works

Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents

Martich, G. D., Danner, R. L., Ceska, M., & Suffredini, A. F. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.4.1021 · Cited by 444 · see citing works

Preclinical Studies to Predict the Disposition of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Humans: Characterization of in Vivo Efficacy, Pharmacokinetics, and Safety

Kelley, S. K., Harris, L. A., Xie, D., DeForge, L. E., Tótpál, K., Bussiere, J., & Fox, J. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29298-3 · Cited by 439 · see citing works

Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Tracey, K. J., Lowry, S. F., Fahey, T. J., Albert, J. D., Fong, Y., HESSE, D. G., Beutler, B., Manogue, K. R., Calvano, S. E., & Hu, W. M. (1987) · PubMed · Cited by 429 · see citing works

Cachectin/TNF: A Macrophage Protein That Induces Cachexia and Shock

Fong, Y., Lowry, S. F., & Cerami, A. (1988) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860718801200608 · Cited by 19 · see citing works

Brief Definitive Report EFFECT OF y INTERFERON ON CACHECTIN EXPRESSION BY MONONUCLEAR PHAGOCYTES Reversal of the lpsd (Endotoxin Resistance) Phenotype

Beutler, B., Tkacenko, V., Milsark, I. W., Krochin, N., & Cerami, A. (2013)

Cachectin: A Macrophage Protein that Induces a Catabolic State in Infected Animals

Cerami, A. (1987) · Springer eBooks · doi:10.1007/978-3-642-83118-8_30 · Cited by 1 · see citing works

The Common Mediator of Shock, Cachexia, and Tumor Necrosis

Beutler, B., & Cerami, A. (1988) · Advances in immunology · doi:10.1016/s0065-2776(08)60846-9 · Cited by 169 · see citing works